CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The study is focused on skin of color participants who have moderate-to-severe atopic dermatitis. Atopic dermatitis, also referred to as eczema...
Phase 4
Chicago, Illinois, United States and 29 other locations
This study will assess the safety and efficacy of ARQ-151 cream applied once a day for 52 weeks by subjects with atopic dermatitis (eczema)....
Phase 3
Rolling Meadows, Illinois, United States and 91 other locations
the treatment of adults with moderate to severe Atopic Dermatitis (Eczema). OpSCF will be compared to a placebo.OpSCF or placebo will be adm...
Phase 2
Rolling Meadows, Illinois, United States of America and 21 other locations
The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) pre...
Phase 3
West Dundee, Illinois, United States and 41 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
Chicago, Illinois, United States and 179 other locations
for the possible treatment of atopic dermatitis (AD), also called eczema, in adults who have already tried AD treatments taken by mouth or b...
Phase 3
Skokie, Illinois, United States and 120 other locations
Single center, prospective, Open label study of sleep, pruritus and circadian function pre/post 12-weeks of dupilumab treatment in children 6-17 year...
Phase 4
Chicago, Illinois, United States
This study will evaluate the safety, tolerability, and efficacy of ANB032 in subjects with moderate to severe atopic dermatitis (AD).
Phase 2
Merrillville, Indiana, United States and 77 other locations
The purpose of this study is to evaluate the long-term safety and tolerability of ruxolitinib cream in adolescents with Atopic Dermatitis (AD).
Phase 3
Skokie, Illinois, United States and 37 other locations
The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...
Phase 3
Chicago, Illinois, United States and 83 other locations
Clinical trials
Research sites
Resources
Legal